Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Crisil Ratings revises ratings outlook of Venus Pipes to 'positive'
Venus Pipes and Tubes (VPTL) said that Crisil Ratings has revised its outlook on the long-term bank facilities of the company to 'positive' from 'stable' while reaffirming the rating at 'Crisil A'.
Venus Pipes Q4 FY26 Results | Jupiter Wagons Signs Long-Term Supply Pact | Top Buzzing Stocks Today - Equitymaster
Venus Pipes Q4 FY26 Results | Jupiter Wagons Signs Long-Term Supply Pact | Top Buzzing Stocks TodayEquitymaster
Venus Pipes jumps 6% after Q4 results; here's why Antique remains bullish
Analysts at Antique Stock Broking maintained a 'Buy' rating on the stock with a target price of ₹1,593 per share (unchanged from ₹1,592 earlier), based on a target FY28E P/E multiple of 17x
Venus Pipes commissions fittings facility and expanded seamless pipes project
Venus Pipes & Tubes has commenced commercial operations of its fittings facility along with the commissioning of additional seamless pipes / tubes capacity today.
Venus Pipes rises after commissioning additional seamless pipes & tubes capacity
Venus Pipes & Tubes advanced 3.81% to Rs 1,468 after the company announced the commencement of commercial operations of its fittings facility along with the commissioning of additional seamless pipes / tubes capacity.
Sebi clears IPOs of Hindustan Labs, RK Steel Manufacturing Co Ltd
Generic drug maker Hindustan Laboratories and steel tubes and pipes manufacturer RK Steel Manufacturing Company have secured Sebi's approval to raise funds through initial public offerings (IPOs), an update with the markets regulator showed on Thursday. The two companies, which filed their preliminary IPO papers in September, obtained Sebi's observations on April 27. In Sebi's parlance, obtaining observations is equivalent to securing approval to float a public offering. Hindustan Laboratories' maiden public offering comprises a fresh issue of 50 lakh shares, along with an offer for sale (OFS) of 91 lakh shares by the promoter, according to the draft red herring prospectus (DRHP). The company proposes to utilise IPO proceeds for funding the working capital requirements and general corporate purposes. Hindustan Laboratories is an Indian pharmaceutical company primarily engaged in the large-scale manufacturing and supply of generic medicines to government institutions under a ...